How tesamorelin is obtained in the UAE: what it is, why it belongs with an assessment, how a batch is verified, and what is reviewed before any program starts.
Tesamorelin has been around long enough that the literature on it is genuinely deep, which makes the sourcing side stranger than it should be. There is real clinical data behind this compound, and yet the market is full of listings that show you nothing except a price and a stock photo of a vial. The useful question is not just where to buy tesamorelin in the UAE, it is how you get it through a route that can tell you whether you should be on it.
This guide covers what tesamorelin is, why its regulatory position is unusual, the two tests that tell you whether a batch is real, how to store it, and what is assessed before anything starts.
Tesamorelin is a stabilised synthetic analogue of growth-hormone-releasing hormone (GHRH). More precisely, it is a modified version of GRF 1-44, the natural 44-amino-acid GHRH fragment, engineered so the molecule holds up better than the native peptide it is based on. That stabilisation is the point: unmodified GHRH degrades quickly, and the modifications to tesamorelin are what let it last long enough to do anything.
In the literature it appears in work on visceral adipose tissue, IGF-1 modulation, and broader metabolic and body-composition outcomes. It is also one of the few GHRH-analogue compounds to have reached approved clinical use in a specific indication in some jurisdictions, which is unusual for this class.
An approval is always for a defined indication, in a defined population, at a defined dose. Tesamorelin's is narrow. Being approved somewhere for something is not the same as being appropriate for you, and it is certainly not a reason to order it and work the dose out yourself.
GHRH analogues act on the growth-hormone axis. That means they interact with glucose handling, with IGF-1 levels, and with a set of conditions where raising IGF-1 is specifically the wrong idea. Those are not things you can screen yourself for from a product page. They are the reason this belongs with bloods, someone who can read them, and a route that will say no where no is the right answer.
Two questions decide whether a batch of tesamorelin is worth anything. Is it pure, and is it actually tesamorelin? They sound identical. They are not, and each has its own test.
Purity comes from high performance liquid chromatography (). It separates everything in the sample and reports each component as a percentage, so a genuine HPLC result gives you an actual number, 98.6 percent, for instance, not a fuzzy "high purity" claim. Identity comes from (MS), which weighs the molecule and confirms it matches what tesamorelin should weigh. Purity without identity tells you the vial is clean but says nothing about what is in it. Identity without purity confirms the right peptide is present but not how much of the vial is something else. You want both, tied to the exact batch.
A (CoA) is the lab report for one production batch. You do not need to be an analytical chemist to check one, and you are entitled to see it. Look for five things:
The lab name you will see most often in this space is Janoshik Analytical, a European lab used widely precisely because its reports can be checked through its own portal. Your consultant can show you the Janoshik report for the specific batch in your program. The full tesamorelin reference covers the compound in more depth.
Tesamorelin is supplied lyophilised, freeze-dried into a small pellet or film, and in that state it is reasonably stable. It is not indestructible. Unopened vials belong at 2 to 8 degrees Celsius and out of the light. Once reconstituted, refrigerated, and used within a few weeks.
In UAE heat that matters more than it sounds. A peptide that spends two days on a warm loading dock can turn a 99 percent CoA into nothing much at all, and you will not be able to tell by looking at it. A cold chain either exists or it does not.
Baseline is a consultation-led service, not a shop. You do not buy tesamorelin here and we do not ship it to you on request.
You complete a short assessment, your consultant reads your history and your medications, and you have a consultation. Because this compound sits on the growth-hormone axis, that review looks specifically at glucose handling, IGF-1, and the contraindications that come with raising it. If therapy is appropriate, it is set out, dosed and monitored with follow-up bloods. If it is not, you are told that, with the reasoning.
Every batch carries independent Janoshik documentation, and your consultant will show you the report for the batch you are given. You can see who you will be speaking to before you book. The consultation is AED 350, credited against your program if you go ahead.
This article is educational and is not a diagnosis, a treatment plan, or a recommendation to use any specific compound. A consultation decides what is appropriate for you.

What tesamorelin is, how the GHRH analogue works, what the visceral fat and liver fat trials show, and how a consultatio...

Learn how to read a peptide Certificate of Analysis. What HPLC purity percentages mean, how to interpret a chromatogram,...

How peptide therapy works in the UAE: verifying purity and identity, reading a batch Certificate of Analysis, spotting g...
Reading is not a diagnosis. A consultation goes through your history with you and tells you plainly whether a program fits, including when it does not. AED 350, credited in full against your first order.